Session Details

F038 Autoimmune Blistering Diseases: What's New?

Sat, Mar 28, 12:00 AM - 12:00 AM
Room 301
2 CME Available Forum
View Map

DESCRIPTION

This session will focus on new advances in AIBD regarding the current treatments and treatments in trials for pemphigus, pemphigoids, LABD and EBA, along with how these may change the way these conditions are managed.

LEARNING OBJECTIVES

1.

Discuss the evidence behind current and new treatments for pemphigoid and how this will change clinical practice

2.

Discuss the evidence behind current treatments and treatments in trials for pemphigus and pitfalls in trial design

3.

Discuss the current and potential new treatments in trials for LABD, MMP and EBA

SCHEDULE

1:00 PM

Introduction to session and speakers

Dedee F. Murrell, MD, FAAD

1:05 PM

Evidence based treatment for pemphigus

Victoria P. Werth, MD, FAAD

1:25 PM

Biological treatments for Bullous pemphigoid

Dedee F. Murrell, MD, FAAD

1:45 PM

A debate - methotrexate is better for bullous pemphigoid maintenance

Pascal Joly, MD, PhD, IFAAD

2:00 PM

A debate : dupilumab is better for control of BP

Frederic Caux, PhD

2:15 PM

Q & A and voting over debate

2:35 PM

Management of Linear IgA bullous dermatosis

Aikaterini Patsatsi, MD, PhD, IFAAD

DIRECTOR

Dedee F. Murrell, MD, FAAD

Dedee F. Murrell, MD, FAAD

SPEAKERS

Frederic Caux, PhD

Frederic Caux, PhD

Pascal Joly, MD, PhD, IFAAD

Pascal Joly, MD, PhD, IFAAD

Aikaterini Patsatsi, MD, PhD, IFAAD

Aikaterini Patsatsi, MD, PhD, IFAAD

Victoria P. Werth, MD, FAAD

Victoria P. Werth, MD, FAAD

HANDOUTS

Login to view handouts

DISCLOSURES

Frederic Caux, PhD

arGEN-X – Investigator(Fees); Boehringer Ingelheim – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Galderma – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Speaker(Honoraria); Regeneron – Investigator(Fees); Sanofi – Advisory Board(Honoraria), Speaker(Honoraria);

Pascal Joly, MD, PhD, IFAAD

AbbVie – Consultant (1099 relationship)(Fees); arGEN-X – Consultant(Honoraria); AstraZeneca – Consultant(Honoraria); BMS – Advisory Board(Honoraria); Glycoera – Consultant (1099 relationship)(Honoraria); janssen – Advisory Board(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); sanofi-aventis – Consultant(Honoraria); TOPAZ Pharmaceuticals, Inc. – Consultant(Honoraria); UCB – Advisory Board(Honoraria);

Dedee F. Murrell, MD, FAAD

AbbVie – Investigator(Grants/Research Funding); Actavis – Speaker/Faculty Education(Honoraria); Almirall – Consultant(Honoraria); Alumis – Investigator(Fees); Amgen – Investigator(Fees); Amicus Therapeutics – Advisory Board(Honoraria); Amryt Pharma – Investigator(Fees); Anacor Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Apogee Therapeutics – Investigator(Fees); Arena Pharmaceuticals – Investigator(Grants/Research Funding); arGEN-X – Investigator(Fees); Ascent Pharmaceuticals – Speaker(Honoraria); Attovia Therapeutics – Investigator(Fees); Bambusa Therapeutics Inc – Advisory Board(Fees); BMS – Investigator(Fees); Castle Creek Pharmaceuticals – Consultant(Fees); Chiesi Farmaceutici – Advisory Board(Fees); CSL – Speaker(Honoraria); Delfin Technology – Investigator(Equipment); Eli Lilly and Company – Advisory Board(Honoraria); Evelo Biosciences, Inc. – Investigator(Fees); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Investigator(Other Financial Benefit); Incyte – Investigator(Fees); Johnson & Johnson – Investigator(Grants/Research Funding); Krystal Biotech, Inc – Other(No Compensation Received); L'Oreal – Speaker(Fees); Leo Pharma Inc – Speaker/Faculty Education(Honoraria); Medimmune – Investigator(Fees), Investigator(Grants/Research Funding); Nektar Therapeutics – Investigator(Fees); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ono – Advisory Board(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Pierre Fabre Dermo-Cosmétique US – Speaker(Honoraria); Principia Biopharma Inc – Consultant(Honoraria); RAPT Therapeutics – Advisory Board(Fees); Regeneron Pharmaceuticals Inc – Advisory Board(Fees); RHEACELL – Data Safety Monitoring Board(Fees); Roche Laboratories – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees), Investigator(Fees), Investigator(Grants/Research Funding); Schering-Plough Corporation – Investigator(Grants/Research Funding); Shire – Advisory Board(Honoraria), Investigator(Grants/Research Funding); TWi Biotechnology, Inc. – Advisory Board(Fees), Investigator(Fees); UCB – Investigator(Fees); UpToDate – Other(Fees);

Aikaterini Patsatsi, MD, PhD, IFAAD

AbbVie – Speaker(Honoraria); Argenx – Advisory Board(Honoraria); Innovaderm Research Inc. – Advisory Board(Honoraria); Johnson and Johnson – Speaker(Honoraria); Leo Pharma Inc – Speaker(Honoraria); Novartis Hellas – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Pharmaserv Lilly – Speaker(Honoraria); Sanofi – Speaker(Honoraria); UCB – Speaker(Honoraria);

Victoria P. Werth, MD, FAAD

AbbVie – Consultant (1099 relationship)(Fees); Almirall – Consultant (1099 relationship)(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); Architect Therapeutics – Consultant (1099 relationship)(Fees); argenx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Arionix – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Atticus Pharma, Inc. – Consultant (1099 relationship)(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Consultant(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Celexor Bio – Consultant (1099 relationship)(Fees); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); Daiichi Sanko – Consultant (1099 relationship)(Honoraria); Dianthus Therapeutics – Consultant (1099 relationship)(Honoraria); Duality Bio – Consultant (1099 relationship)(Fees); EMD Serono – Consultant(Honoraria), Investigator(Grants/Research Funding); First Tracks Biotherapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Glycoera – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Innovaderm Research Inc. – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Odyssey Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Prolium – Consultant (1099 relationship)(Honoraria); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Sanofi Aventis – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); Valuence – Consultant (1099 relationship)(Honoraria); Vindico Medical Education – Speaker/Faculty Education(Honoraria);